Skip to main content
. Author manuscript; available in PMC: 2007 Oct 23.
Published in final edited form as: Pharm Res. 2005 Sep 22;22(10):1700–1707. doi: 10.1007/s11095-005-6335-8

Fig. 3.

Fig. 3

Inhibition of PMA-induced human neutrophil superoxide anion (O2•−) production by three different nebulized formulations of tPA as measured by the rate of cytochrome c reduction (mM min−1). production Formulations #1 (A), #25 (B), and #27 (C) reduced O2•− by 84, 50, and 58%, respectively. Data represent the mean (±SEM) of results from at least seven separate experiments.